Antimicrobial resistance of bacterial pathogens isolated from cancer patients: a systematic review and meta-analysis

  04 March 2025

Antimicrobial resistance (AMR) poses a significant threat to global public health, particularly for cancer patients. A comprehensive review of bacterial pathogens isolated from cancer patients found that resistance prevalence was highest for penicillins in E. coli, followed by cotrimoxazole and monobactams in K. pneumoniae. Acinetobacter baumannii had high resistance prevalence to multiple antimicrobial classes, while Enterobacter spp. and Enterococcus faecium showed high resistance prevalence to penicillins. The high prevalence of AMR, especially among ESKAPE pathogens, highlights the urgent need for improved infection prevention and antimicrobial stewardship in cancer care.

Further reading: BMC Infectious Diseases
Author(s): Onyansaniba K. Ntim et al
Healthy Patients  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!